Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].

Ai zheng = Aizheng = Chinese journal of cancer - 1 Mar 2003

Zhang Yi, Ji Shu-Rong, Feng Dian-Xu, Ji Jun, Han Tian-Quan

Abstract excerpt

BACKGROUND & OBJECTIVE: The early diagnosis of pancreatic carcinoma is difficult. The serum tumor markers such as CA19-9 have a relatively high sensitivity but with low specificity. The oncogene K-ras is frequently mutated in pancreatic carcinoma and with high specificity. The aim of this study was to assess the feasibility of detection of K-ras mutation combined with serum content of CA19-9 as an approach for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to CA-19-9 Antigen

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Mutation

Share to Pancreatic Neoplasms

Share to Polymorphism, Restriction Fragment Length

Share to Prognosis

Source

Identifiers

PMID: 12654190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].PMID 12654190Read ↗

[Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].Semantic proximity Read ↗

[The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].Semantic proximity Read ↗

Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.Semantic proximity Read ↗

A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.Semantic proximity Read ↗

[An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].Semantic proximity Read ↗

[Clinical usefulness of tumor markers associated with pancreatic cancer].Semantic proximity Read ↗

Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.Semantic proximity Read ↗

Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.Semantic proximity Read ↗

Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.Semantic proximity Read ↗

[Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].Semantic proximity Read ↗

[Molecular factors of pancreatic cancer pathogenesis and prognosis].Semantic proximity Read ↗

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.